Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. - Li,Y.; Kucuk,O.; Hussain,M.; Abrams,J.; Cher,M.L.; Sarkar,F.H. (Cancer Res, 2006)